Martine Jandrot-Perrus

11PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 02, 2025
Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs.

Pierre H Mangin, Martine Jandrot-Perrus

|Jan 17, 2025
Comparative Effects of Glenzocimab and Eptifibatide on Bleeding Severity in 2 Mouse Models of Intracranial Hemorrhage.

Sébastien Dupont, Héloïse Lebas, Sabrina Mavouna

|May 13, 2024
Platelets favor the outgrowth of established metastases.

Maria J Garcia-Leon, Cristina Liboni, Vincent Mittelheisser

|Feb 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.

Marie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille

|Nov 14, 2022
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.

Philippe Billiald, Alexandre Slater, Martin Welin

|Sep 23, 2022
Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1.

Ilaria De Simone, Constance C F M J Baaten, Martine Jandrot-Perrus

Pageof 2